A Life-Extending Study for Colorectal Cancer Patients with Inoperable Liver Metastases - Takeaways - MDSpire

A Life-Extending Study for Colorectal Cancer Patients with Inoperable Liver Metastases

Physicians at Fox Chase Cancer Center have begun accepting patients for a new clinical trial looking at the effectiveness of a hepatic artery infusion (HAI) pump along with standard chemotherapy. Fox Chase is the only local hospital offering this trial, which is designed for patients with colorectal cancer that has spread to the liver and cannot be treated with surgery.

  • By

  • September 13, 2025

  • 3 min

Share

  • 1

    Fox Chase Cancer Center is conducting a clinical trial for colorectal cancer patients with inoperable liver metastases.

  • 2

    The trial evaluates the effectiveness of a hepatic artery infusion pump combined with standard chemotherapy.

  • 3

    HAI pumps deliver the chemotherapy drug floxuridine directly to the liver, potentially allowing for future surgeries.

  • 4

    The trial aims to improve patient survival by assessing the combination treatment's effectiveness compared to chemotherapy alone.

  • 5

    The PUMP Trial is funded by the National Cancer Institute and is now open for patient enrollment at Fox Chase.

Original Source(s)

A Life-Extending Study for Colorectal Cancer Patients with Inoperable Liver Metastases

  • by

  • September 13, 2025

Related Content

Biotech exec Jeremy Levin on the industry’s strategic turning point

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity